Aura Biosciences, Inc. (AURA) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
05M10M15M20M25M30M35M40MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EBITDA

EBITDA
-40M-35M-30M-25M-20M-15M-10M-5M1Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Income Variation (%)

Gross Profit VariationOperating Income Variation
048111519222630Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
0510152025303540Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Price-to-Earning Ratio

P/E Ratio
-7-6-5-4-3-2-101Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0750K2M2M3M4M4M5M6MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
025M50M75M100M125M150M175M200MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
011M22M34M45M56M68M79M90MQ3 2024Q4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics